MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens

Phase 4
Completed
Conditions
Cataract
Interventions
Device: AcrySof Toric IOL
First Posted Date
2008-09-26
Last Posted Date
2012-01-16
Lead Sponsor
Alcon Research
Target Recruit Count
120
Registration Number
NCT00760487
Locations
🇺🇸

Alcon Call Center, Fort Worth, Texas, United States

Safety and Efficacy of Travoprost/Timolol BAC-free

First Posted Date
2008-09-26
Last Posted Date
2014-07-16
Lead Sponsor
Alcon Research
Target Recruit Count
87
Registration Number
NCT00760539
Locations
🇯🇵

Manabe Clinic, Hamura, Tokyo, Japan

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

Phase 4
Completed
Conditions
Glaucoma
Interventions
First Posted Date
2008-09-25
Last Posted Date
2014-01-13
Lead Sponsor
Alcon Research
Target Recruit Count
86
Registration Number
NCT00759941
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Visual Function After Bilateral Implantation of AcrySof® Toric

Phase 4
Completed
Conditions
Visual Function
Interventions
Device: AcrySof® Toric IOL
Device: AcrySof Natural
First Posted Date
2008-09-25
Last Posted Date
2010-03-16
Lead Sponsor
Alcon Research
Target Recruit Count
60
Registration Number
NCT00758550
Locations
🇺🇸

Alcon Call Center, Fort Worth, Texas, United States

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Phase 4
Completed
Conditions
Open-angle Glaucoma
Ocular Hypertension
Interventions
First Posted Date
2008-09-25
Last Posted Date
2016-11-22
Lead Sponsor
Alcon Research
Target Recruit Count
36
Registration Number
NCT00759239
Locations
🇬🇧

Western Eye Hospital, London, United Kingdom

ReSTOR Natural +3.0D Study In Japan

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1
First Posted Date
2008-09-25
Last Posted Date
2010-12-21
Lead Sponsor
Alcon Research
Target Recruit Count
64
Registration Number
NCT00758576
Locations
🇯🇵

Hayashi Eye Hospital, Fukuoka, Japan

Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time

Phase 2
Completed
Conditions
Dry Eye Disease
Interventions
Drug: Hydroxypropyl Guar Galactomannan
First Posted Date
2008-09-25
Last Posted Date
2010-01-06
Lead Sponsor
Alcon Research
Target Recruit Count
40
Registration Number
NCT00760045
Locations
🇯🇵

Osaka Pharmacology Clinical Research Hospital, Osaka, Japan

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Not Applicable
Completed
Conditions
Visual Acuity
Interventions
Device: RESTOR IOL Model SA60D3
First Posted Date
2008-09-25
Last Posted Date
2023-12-05
Lead Sponsor
Alcon Research
Target Recruit Count
30
Registration Number
NCT00759096
Locations
🇺🇸

Alcon Call Center, Fort Worth, Texas, United States

Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)

Phase 4
Terminated
Conditions
Intraocular Pressure
Interventions
First Posted Date
2008-09-25
Last Posted Date
2023-12-05
Lead Sponsor
Alcon Research
Target Recruit Count
37
Registration Number
NCT00758342

Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL

Phase 4
Withdrawn
Conditions
Cataract
Interventions
Device: Akreos® MI60 intraocular lens
Device: AcrySof® IQ IOL
Device: Tecnis® Aspheric intraocular lens
First Posted Date
2008-09-25
Last Posted Date
2015-05-12
Lead Sponsor
Alcon Research
Registration Number
NCT00760058
Locations
🇺🇸

Alcon Call Center, Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath